Literature DB >> 9165638

Course and outcome for schizophrenia versus other psychotic patients: a longitudinal study.

M Harrow1, J R Sands, M L Silverstein, J F Goldberg.   

Abstract

We studied 276 patients longitudinally, beginning at the acute phase and continuing at three successive followups over 7.5 years, comparing 74 schizophrenia patients with 74 other psychotic patients and 128 nonpsychotic patients on early course and outcome. Schizophrenia patients showed significantly poorer functioning than patients with other psychotic disorders at each of the three followups (p < 0.05). More schizophrenia patients than other psychotic patients showed consistent psychopathology and a course in which there was not complete remission at any of the three followups (p < 0.05). Most schizophrenia patients did not show severe decrements in social activity level. Poor outcome schizophrenia patients showed significantly slower recovery at each followup than did other psychotic patients with initial poor outcomes (p < 0.01). The results indicate that, during the early course, schizophrenia patients still show relatively poor outcomes, although a small number of schizophrenia patients enter into complete remission. Over time, many schizophrenia patients fluctuate between severe disability and moderate disability rather than always showing severe disability. Schizophrenia patients tend to recover more slowly then other psychotic patients. Differences between schizophrenia patients and other psychotic patients in clinical course over time may be larger than differences at any single followup.

Entities:  

Mesh:

Year:  1997        PMID: 9165638     DOI: 10.1093/schbul/23.2.287

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  22 in total

Review 1.  Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.

Authors:  Robert E McCullumsmith; John Hammond; Adam Funk; James H Meador-Woodruff
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

2.  Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk.

Authors:  D D McAlpine; D Mechanic
Journal:  Health Serv Res       Date:  2000-04       Impact factor: 3.402

3.  The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.

Authors:  Eva Velthorst; Anne-Kathrin J Fett; Avraham Reichenberg; Greg Perlman; Jim van Os; Evelyn J Bromet; Roman Kotov
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

4.  The long-term effects of placebo in patients with chronic schizophrenia.

Authors:  R J Wyatt; I D Henter; J J Bartko
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

5.  Knowledge and insight in relation to functional remission in patients with long-term psychotic disorders.

Authors:  Malin Alenius; Margareta Hammarlund-Udenaes; Per Hartvig; Leif Lindström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-21       Impact factor: 4.328

6.  Locus of control: relation to schizophrenia, to recovery, and to depression and psychosis -- A 15-year longitudinal study.

Authors:  Martin Harrow; Barry G Hansford; Ellen B Astrachan-Fletcher
Journal:  Psychiatry Res       Date:  2009-07-01       Impact factor: 3.222

7.  Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.

Authors:  Gregory P Strauss; Martin Harrow; Linda S Grossman; Cherise Rosen
Journal:  Schizophr Bull       Date:  2008-12-18       Impact factor: 9.306

8.  How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up.

Authors:  Martin Harrow; Thomas H Jobe
Journal:  Schizophr Bull       Date:  2008-07-09       Impact factor: 9.306

9.  Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia.

Authors:  Adrienne C Lahti; Martin A Weiler; Henry H Holcomb; Carol A Tamminga; Karen L Cropsey
Journal:  Neuropsychopharmacology       Date:  2009-08-12       Impact factor: 7.853

10.  The abilities of improved schizophrenia patients to work and live independently in the community: a 10-year long-term outcome study from Mumbai, India.

Authors:  Amresh Kumar Srivastava; Larry Stitt; Meghana Thakar; Nilesh Shah; Gurusamy Chinnasamy
Journal:  Ann Gen Psychiatry       Date:  2009-10-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.